Summit Therapeutics (SMMT) Asset Utilization Ratio (2017 - 2024)
Historic Asset Utilization Ratio for Summit Therapeutics (SMMT) over the last 9 years, with Q3 2025 value amounting to 0.0.
- Summit Therapeutics' Asset Utilization Ratio rose 10000.0% to 0.0 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.0, marking a year-over-year increase of 10000.0%. This contributed to the annual value of 0.0 for FY2022, which is 8918.01% down from last year.
- According to the latest figures from Q3 2025, Summit Therapeutics' Asset Utilization Ratio is 0.0, which was up 10000.0% from 0.0 recorded in Q2 2025.
- Summit Therapeutics' 5-year Asset Utilization Ratio high stood at 0.0 for Q3 2022, and its period low was 0.02 during Q2 2024.
- Its 5-year average for Asset Utilization Ratio is 0.0, with a median of 0.0 in 2021.
- In the last 5 years, Summit Therapeutics' Asset Utilization Ratio surged by 1.42345771632289e18% in 2022 and then tumbled by 1.9894594980001632e19% in 2024.
- Over the past 5 years, Summit Therapeutics' Asset Utilization Ratio (Quarter) stood at 0.0 in 2021, then surged by 3849443339699767.0% to 0.0 in 2022, then plummeted by 100.0% to 0.0 in 2023, then crashed by 1.655573241556374e17% to 0.01 in 2024, then soared by 100.0% to 0.0 in 2025.
- Its Asset Utilization Ratio stands at 0.0 for Q3 2025, versus 0.0 for Q2 2025 and 0.01 for Q1 2025.